A “reasonable decision” must be made on providing medicines for children with Duchenne syndrome, Prime Minister Irakli ...
Orphan drug designation from the European Commission underscores Solid’s commitment to advance SGT-003 through a global ...
Caught in the tense space between life and death, 11-year-old Anas Mohammed Allam battles a relentless condition of Duchenne ...
On Tuesday, Cumberland (NASDAQ: CPIX) discussed first-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for high unmet need ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
Epicrispr Biotechnologies (“Epicrispr”), a clinical-stage company pioneering gene-modulating therapies, and Forge Biologics (“Forge”), a leading manufacturer of gene therapies and member of the ...
Stocktwits on MSN
ATOS stock jumps 8% today – an FDA designation draws investor cheer for Atossa Therapeutics
The RPD designation is given to therapies targeting serious or life-threatening conditions that primarily affect children. ・(Z)-endoxifen already has an RPD designation for the treatment of Duchenne ...
New guidance from reimbursement authority NICE has recommended Rystiggo (rozanolixizumab) for people with gMG who test ...
The Minister of Health, Mikheil Sarjveladze, was heard in Parliament while a rally of parents of children with Duchenne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results